Clinical Trial

Efficacy of Topical Tapinarof Versus Betamethasone in the Treatment of Plaque Psoriasis

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
To assess the effectiveness of topical tapinarof to topical betamethasone in patients with mild to moderate plaque psoriasis presenting to tertiary care hospital in Islamabad
Trial Details
NCT Number NCT07635043
Lead Sponsor Pakistan Institute of Medical Sciences
Conditions Psoriasis (PsO)
Enrollment 120 participants
Start Date 2026-08-01
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-09